Advertisement

Topics

Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD) Company Profile

01:07 EST 20th November 2017 | BioPortfolio


News Articles [2818 Associated News Articles listed on BioPortfolio]

Johnson & Johnson, HHS partner on influenza

Johnson & Johnson announced that Janssen Research & Development are collaborating with the HHS’ Office of the Assistant Secretary for Preparedness and Response (ASPR) to develop a comprehens...

Johnson & Johnson Posting Notable Gain After Upgrade By Jefferies

NEW BRUNSWICK (dpa-AFX) - Shares of Johnson & Johnson (JNJ) have shown a notable move to the upside during trading on Wednesday, climbing by 2 percent. With the upward move, Johnson & Johnson has ...

Proteros teams up with Johnson & Johnson Innovation on sub-class of epigenetic targets

Proteros biostructures GmbH announced today that the company has entered into a collaboration with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, on a sub-cl...

Johnson & Johnson tops 2Q profit forecasts

This Tuesday, Sept. 13, 2016, file photo, shows Johnson & Johnson Band-Aid brand bandages in Surfside, Fla.

Johnson & Johnson: The Fundamentals of Alliance Management

Johnson & Johnson were one of the first companies to realise the importance of an alliance management group closely following in rival Eli Lilly & Co.’s footsteps. Rob Wills, VP Alliance Management ...

A Corporate Law Takeaway From Judge Nelson's Ruling In The Talcum Powder Case

After a three week trial that included extensive expert testimony, a Los Angeles jury returned a $417 million verdict against Johnson & Johnson and its subsidiary Johnson & Johnson Consumer, I...

Johnson & Johnson: Wait For The Drop Or Take The Shot?

This company tracks the S&P 500 index heavily, and thus waiting for a pullback may not be a feasible strategy in a bullish marketplace. Johnson & Johnson has undoubtedly had quite a good ride ...

Johnson Johnson caught in another scandal, forced to pay $33 million ...

Johnson & Johnson is set to dole out up to $33 million in settlement with 42 states over allegations that a subsidiary of the pharmaceutical drug giant sold nonprescription medicines that did not ...

PubMed Articles [3526 Associated PubMed Articles listed on BioPortfolio]

Cefepime Associated With Phenytoin Induced Stevens-Johnson Syndrome.

We describe a recent case of Stevens-Johnson Syndrome. A 49-year-old man was admitted to the Intensive Care Unit of an Anaesthesia and Resuscitation Department because of a Fournier gangrene that deri...

Human Leukocyte Antigen Class I Genes Associated With Stevens-Johnson Syndrome and Severe Ocular Complications Following Use of Cold Medicine in a Brazilian Population.

Describing the association with human leukocyte antigen (HLA) alleles could facilitate the understanding of increased risk factors for development of Stevens-Johnson syndrome (SJS) and toxic epidermal...

Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Standard Reporting and Evaluation Guidelines: Results of a National Institutes of Health Working Group.

Toxic epidermal necrolysis (TEN) and Stevens-Johnson Syndrome (SJS) are rare, acute, life-threatening dermatologic disorders involving the skin and mucous membranes. Research into these conditions is ...

Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Associations, Outcomes, and Pathobiology-Thirty Years of Progress but Still Much to Be Done.

Although rare, Stevens-Johnson syndrome and toxic epidermal necrolysis remain among the most devastating of acute conditions involving the skin. In the past 30 years, tremendous progress has been made...

Are steroids effective in toxic epidermal necrolysis and Stevens-Johnson syndrome?

Toxic epidermal necrolysis and Stevens-Johnson syndrome are severe adverse skin reactions to medications and infections. Steroids are described as a therapeutic alternative, but their use is still con...

Clinical Trials [3240 Associated Clinical Trials listed on BioPortfolio]

Stevens-Johnson Syndrome Antimicrobial

Steven-Johnson's syndrome, or great multiform erythema, appears as a systemic disturbance, with skin involvement and mucous membranes, related to several factors, such as, viral or bacteri...

A Relative Bioavailability Study of 20 mg Famotidine Tablets Under Fed Condition

The study was conducted as an open-label, balanced, randomized, two-treatment, two-period, two-sequence, single-dose, crossover, bioavailability study comparing famotidine tablets, USP 20 ...

A Relative Bioavailability Study of 20 mg Famotidine Tablets Under Fasting Condition

The study was conducted as an open-label, balanced, randomized, two-treatment, two-period, two-sequence, single-dose, crossover, bioavailability study comparing famotidine tablets, USP 20 ...

Phase III Clinical Trial of NPB-01 in Patients With Stevens-Johnson Syndrome/ Toxic Epidermal Necrolysis Unresponsive to Corticosteroids.

Patients diagnosed with Stevens-Johnson syndrome and Toxic Epidermal Necrolysis were confirmed based on the investigators national diagnostic criteria. Patients who meet all inclusion crit...

Extracorporeal Photopheresis Pilot Study

ECP will be given to the patients [UVAR®XTS TM Therakos system, Johnson & Johnson] according to the following schedule: Starting at day 21 after transplant, if hematologic recovery allow...

Companies [5498 Associated Companies listed on BioPortfolio]

Johnson & Johnson Pharmaceutical Research and Development, L.L.C.

Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD) is a wholly-owned subsidiary of Johnson & Johnson, the world's most broadly based producer of health care ...

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD) is a wholly-owned subsidiary of Johnson & Johnson, the world's most broadly based producer of health care ...

Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD)

Janssen(R), Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.

Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD) is headquartered in Raritan, New Jersey (USA), and has nine sites throughout Europe and the United States. J&JPRD employs appro...

Johnson & Johnson Innovation

The London Innovation Centre is part of Johnson & Johnson Innovation, a division of Johnson & Johnson Finance Limited. Johnson & Johnson Innovation focuses on accelerating early i...

More Information about "Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD)" on BioPortfolio

We have published hundreds of Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD) news stories on BioPortfolio along with dozens of Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD) Clinical Trials and PubMed Articles about Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD) for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD) Companies in our database. You can also find out about relevant Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD) Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record